KRAS and non-small cell lung carcinoma: Evidence that AMPK promoted tumorigenesis was likewise observed in in vivo model of NSCLC in which AMPKα1α2 double knockout together with mutant K-RAS and P53 deletion was found to retard the magnitude and the number of tumors [47].